The expression of the receptor protein tyrosine phosphatase r-PTPg is drastically reduced in rat and human malignant thyroid cells, whereas its restoration reverts the neoplastic phenotype of retrovirally transformed rat thyroid cells. Moreover, reduced levels and loss of heterozygosity of DEP-1, the human homolog of r-PTPg, have been found in many human neoplasias. Here, we report that the r-PTPg protein binds to c-Src in living cells and dephosphorylates the c-Src inhibitory tyrosine phosphorylation site (Tyr 529), thereby increasing c-Src tyrosine kinase activity in malignant rat thyroid cells stably transfected with r-PTPg. Tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin was enhanced in r-PTPg-expressing cells. This was associated with increased adhesion of malignant r-PTPg-transfected thyroid cells vs both untransfected cells and cells stably transfected with an inactive r-PTPg mutant. Treatment of rat thyroid cells with the c-Src inhibitor PP2 decreased cell adhesion to a higher extent in r-PTPg-transfected cells than in mock-transfected or stably transfected cells with the inactive r-PTPg mutant, indicating that r-PTPg regulates cell-substratum adhesion by activating c-Src. Interestingly, the extent of both c-Src dephosphorylation at Tyr 529, FAK and paxillin phosphorylation, and the increased cell adhesion were associated with the degree of r-PTPg expression.
Introduction
The r-PTPZ gene, isolated in our laboratory (Zhang et al., 1997) , encodes a receptor-type protein tyrosine phosphatase constituted by an extracellular region containing eight type III fibronectin repeats, a transmembrane region and an intracellular region containing a single catalytic domain. A large body of evidence implicates r-PTPZ in tumor transformation. Indeed, r-PTPZ gene expression is suppressed in retrovirally infected cells that display a highly malignant phenotype, that is, rat thyroid PC Cl3 and FRTL-5 Cl2 cells, which are transformed by the myeloproliferative sarcoma virus and by the Kirsten murine sarcoma virus, respectively (Zhang et al., 1997; Martelli et al., 1998; Florio et al., 2001) . HPTPZ/DEP-1, the human homolog of r-PTPZ, is drastically reduced in human thyroid carcinomas (Trapasso et al., 2000) . Restoration of r-PTPZ expression in malignant rat thyroid cells and in human thyroid carcinoma cell lines inhibits their growth and tumorigenicity (Trapasso et al., 2000; Iuliano et al., 2003) . HPTPZ/DEP-1 is upregulated in some cell lines as cell density increases (Ostman et al., 1994; Iuliano et al., 2003) , and it inhibits the growth of breast cancer cell lines (Keane et al., 1996) . Loss of heterozygosity at the locus of this gene is frequent in human colon, lung, breast and thyroid cancers (Ruivenkamp et al., 2002 (Ruivenkamp et al., , 2003 Iuliano et al. 2004) . Lastly, the mouse homolog of HPTPZ/DEP-1/PTPRJ gene, Ptprj, is the candidate for the mouse colon cancer susceptibility locus Scc1 (Ruivenkamp et al., 2002) .
The identification of the interacting proteins and physiological substrates of r-PTPZ might shed light on the biochemical pathways through which r-PTPZ/DEP-1 acts. Dephosphorylation by DEP-1 of the PDGFb, HGF and VEGF receptors at specific sites results in impaired signal transduction (Kovalenko et al., 2000; Lampugnani et al., 2003; Palka et al., 2003) . This finding could explain some of the growth inhibition properties of DEP-1. DEP-1, also known as CD148, impairs T-cell activation (de la Fuente-Garcia et al., 1998; Tangye et al., 1998; Baker et al., 2001) probably by decreasing tyrosine phosphorylation of LAT and PLCg1 (Baker et al., 2001) . The role of DEP-1 in cell confluence inhibition may be related to its interaction with components of the cell-cell adhesion complex, that is, b-catenin and plakoglobin (Palka et al., 2003) , and in particular to the dephosphorylation of p120 catenin DEP-1-mediated (Holsinger et al., 2002) . In addition, syntenin, an r-PTPZ-interacting protein , is able to bind proteins of the cell-cell adhesion complex (Zimmermann et al., 2001) . Finally, the reintroduction of the r-PTPZ gene into malignant rat thyroid cells increased their adhesion to the substratum (Trapasso et al., 2000) .
Src kinase has long been known to be involved in cellsubstratum adhesion. Knockout of the Src gene affects the cells' adhesive properties (Kaplan et al., 1995) . In Src-transformed cells, increased adhesion to the plate surface is accompanied by tyrosine phosphorylation of the focal adhesion proteins FAK and paxillin (Guan and Shalloway, 1992; Thomas et al., 1995) . c-Src activity is regulated by the phosphorylation status of two tyrosine sites: Tyr 527 and Tyr 416 (chicken Src numbering). The carboxy-terminal Tyr 527, after its phosphorylation, interacts with the c-Src SH2 domain. Consequent to this intramolecular binding, c-Src remains in an inactive conformation and does not exert tyrosine kinase activity (Roussel et al., 1991; Xu et al., 1997) . Several tyrosine phosphatases can activate c-Src by dephosphorylating phosphotyrosine 527 (Bjorge et al., 2000) , thereby counteracting the activity of c-Src terminal kinase (csk) on this aminoacid (Nada et al., 1991) . Conversely, dephosphorylation of the second regulatory site of c-Src, Tyr 416, leads to inhibition of c-Src tyrosine kinase activity (Bjorge et al., 2000) . In some cases, c-Src activation by phosphatase RPTPa leads to an increase in cell adhesion properties (Harder et al., 1998) .
The aim of this study was to investigate whether r-PTPZ binds to c-Src and, if so, to examine the effect of this association on cell-substratum adhesion. We report that, in rat malignant thyroid cells, r-PTPZ activates the c-Src protein by dephosphorylating its Tyr 529 residue. Thus, r-PTPZ increases cell-substratum adhesion by activating c-Src-dependent tyrosine phosphorylation of FAK and paxillin.
Results

r-PTPZ interacts with c-Src
c-Src might be a good r-PTPZ substrate candidate; in fact, the restoration of r-PTPZ in thyroid malignant cells is associated with increased adhesion to the substratum, and c-Src tyrosine kinase activity is known to be involved in cell adhesion (Harder et al., 1998; Jandt et al., 2003) . Thus, we first investigated whether r-PTPZ interacts with c-Src in an in vitro binding assay. We prepared a GST fusion protein containing the intracellular region of the wild-type r-PTPZ protein (GST-PTPZ). Recombinant proteins were expressed in bacteria and purified as described under 'Materials and methods'. Total cell lysates from PC MPSV cells, which do not express r-PTPZ, were incubated with equal amounts of GST-PTPZ or purified GST protein and immunoprecipitated with c-Src antibodies. Immunoblot analysis of c-Src immunoprecipitates with anti-GST antibodies revealed a band corresponding to GST-PTPZ in lysates incubated with recombinant wild-type r-PTPZ. No co-immunoprecipitation occurred in lysates treated with GST alone (Figure 1a, left panel) . Similar results were obtained with the inactive r-PTPZ mutant GST-PTPZ C/S (Tonks and Neel, 1996) (data not shown).
We next examined the interaction between r-PTPZ and c-Src in co-immunoprecipitation experiments. Lysates from PC MPSV/r-PTPZ cells were immunoprecipitated with anti-c-Src antibodies and immunoprecipitates were immunoblotted with antibodies against r- We next investigated whether r-PTPZ is involved in the control of the phosphorylation status of the two c-Src tyrosine residues (Tyr 529 and Tyr 418). We analysed c-Src dephosphorylation by r-PTPZ in PC MPSV cells either untransfected or stably transfected with the empty vector, the wild-type phosphatase or its inactive mutant. Different clones of PC MPSV/r-PTPZ cells, which express high levels of r-PTPZ, showed c-Src dephosphorylation at Tyr 529 whereas PC MPSV and PC MPSV/r-PTPZ C/S cells did not ( Figure 2a) . Conversely, the phosphorylation status of Tyr 418 did not change in malignant rat thyroid cells overexpressing r-PTPZ or r-PTPZ C/S. Therefore, r-PTPZ specifically dephosphorylates the c-Src inhibitory tyrosine phosphorylation site (Tyr 529) in intact cells. To evaluate whether Tyr 529 dephosphorylation is direct, we immunoprecipitated c-Src from PC MPSV lysates and incubated the immunocomplexes with GST-PTPZ or GST-PTPZ C/S (Figure 2b ). Immunoblot analysis with phosphospecific antibodies that recognize phosphorylated c-Src at Tyr 529 showed decreased phosphorylation in the presence of GST-PTPZ. The extent of phosphorylation of the c-Src inhibitory residue was much lower with 3 mg than with 0.5 mg of GST-PTPZ. As expected, the catalytically inactive mutant GST-PTPZ C/S had no effect on the phosphorylation status of Tyr 529. Using the same assay, we found that Tyr 418 was also dephosphorylated (Figure 2b ), indicating that, in vitro, r-PTPZ is able to dephosphorylate both c-Src regulatory phosphorylation sites.
Src kinase activity is increased in r-PTPZ-overexpressing cells
Our data suggest that c-Src tyrosine kinase is activated by r-PTPZ-induced Tyr 529 dephosphorylation. To further verify this result, we measured c-Src catalytic activity with a Src kinase assay. Endogenous Src was immunoprecipitated from PC MPSV, PC MPSV/r-PTPZ and PC MPSV/r-PTPZ C/S cell extracts with antibodies that do not interfere with Src kinase activity. r-PTPZ overexpression increased Src-specific kinase activity in PC MPSV/r-PTPZ cells by about 2.5-fold compared to PC MPSV cells; c-Src activation was slightly decreased in immunoprecipitates from r-PTPZ C/S-transfected cells. As expected, Src activation in PC MPSV/r-PTPZ cells was accompanied by a decrease in the level of overall Src tyrosine phosphorylation in vivo (Figure 3 ). These results suggest that r-PTPZ is able to regulate cSrc tyrosine kinase activity by dephosphorylating its Tyr 529. Increase of the c-Src activity was also observed in other PC MPSV/r-PTPZ cell clones but not in the PC MPSV stably transfected with the empty vector (data not shown).
Restoration of r-PTPZ expression increases cell-substratum adhesion
We have previously shown that PC MPSV cells, after restoration of r-PTPZ expression by transfection with a wild-type r-PTPZ construct, lose their typical round shape and become more adherent to the plate surface (Trapasso et al., 2000) . This prompted us to quantify the effect of r-PTPZ on cell-substratum adhesion. As reported under 'Materials and methods', we assessed the adhesion to the culture dish of PC MPSV, PC MPSV stably transfected with the empty vector, different PC MPSV/r-PTPZ cell clones and PC MPSV/r-PTPZ C/S cells after they had been washed several times with PBS. As shown in Figure 4a , a significantly higher percent of cells expressing wild-type r-PTPZ remained adherent to the cell culture dish compared with the mock-transfected counterpart. PC MPSV/r-PTPZ C/S cells were signifi- To determine whether c-Src activation is involved in increased adhesion of r-PTPZ-overexpressing cells to the substratum, we performed the adhesion assay with cells treated with the selective Src inhibitor PP2. Incubation of PC MPSV, PC MPSV/r-PTPZ and PC MPSV/r-PTPZ C/S cells with PP2 reduced adhesion to substratum in all the three cell lines examined, and the effect was significantly greater in PC MPSV/r-PTPZ cells (Figure 4b ). These results confirm that r-PTPZ regulates cell-substratum adhesion by activating c-Src tyrosine kinase.
Increase cell-substratum adhesion of r-PTPZ transfected cells is mediated by enhanced Src-dependent FAK and paxillin tyrosine phosphorylation
We next examined the effects of activated c-Src on its substrate FAK, a 125-kDa protein tyrosine kinase rich in focal adhesions (Hanks et al., 1992; Schaller et al., 1992) . Src-induced increase in FAK phosphotyrosine levels (Calalb et al., 1995) is one of the earliest events of adhesion-mediated signal transduction. Thus, we measured the levels of FAK tyrosine phosphorylation in PC MPSV untransfected or stably transfected cell lines by immunoprecipitation with anti-FAK antibodies and Western blotting with anti-phosphotyrosine antibodies. As shown in Figure 5a , FAK phosphotyrosine levels were higher in r-PTPZ-overexpressing cells than in PC MPSV and PC MPSV/r-PTPZ C/S cells. In addition, increased FAK tyrosine phosphorylation was accompanied by a stronger association with Src (data not shown).
Formation of the FAK/Src complex leads to tyrosine phosphorylation of a number of focal adhesion-associated substrates, including the cytoskeletal protein paxillin (Burridge et al., 1992) . We therefore evaluated tyrosine phosphorylation of paxillin by immunoprecipitation and Western blotting. Expression of wild-type r-PTPZ, but not of its mutated form, resulted in greatly increased levels of phosphorylated paxillin (Figure 5b ). To determine whether FAK and paxillin tyrosine phosphorylation were mediated by r-PTPZ-induced Src activation, we treated cells with PP2. Both FAK and The extent of c-Src Tyr 529 dephosphorylation and FAK and paxillin tyrosine phosphorylation correlates with r-PTPZ expression levels
The protein levels of DEP-1, the human homolog of r-PTPZ, are drastically reduced in human thyroid carcinoma, and loss of heterozygosity of DEP-1 has been identified in several human cancers. As DEP-1 downregulation is a crucial event in carcinogenesis (Keane et al., 1996; Trapasso et al., 2000) , we investigated whether differences in r-PTPZ expression could affect c-Src dephosphorylation at Tyr 529. For this purpose, we analysed a representative PC MPSV/ r-PTPZ cell clone (Cl 4) previously used in our study and a PC MPSV/r-PTPZ cell clone expressing lower levels of exogenous r-PTPZ (Cl 5) ( Figure 6a ). As shown in Figure 6b , c-Src dephoshorylation at Tyr 529 paralleled r-PTPZ expression. To examine whether FAK and paxillin tyrosine phosphorylation are affected by r-PTPZ, we immunoprecipitated FAK and paxillin from the two cell clones investigated and probed each immunocomplex with anti-phosphotyrosine antibodies. We observed that FAK and paxillin tyrosine phosphorylation increased with the increase in r-PTPZ expression (Figure 6c and d) . Therefore, r-PTPZ exerts a dosedependent effect on the phosphorylation of c-Src Tyr 529, FAK and paxillin in PC MPSV cells. It is noteworthy that c-Src dephosphorylation at Tyr 529, and the increase of FAK and paxillin tyrosine phosphorylation were also observed in FRTL KiMPSV/r-PTPZ cells in comparison with FRTL KiMPSV untransfected cells (data not shown).
Discussion
The tyrosine phosphatase r-PTPZ suppresses the tumorigenic potential of malignant rat thyroid cells.
The tumor suppressor activity of r-PTPZ has been associated with downregulation of ERK 1 and 2 activity, which in turn leads to stabilization of the p27Kip1 cell cycle inhibitor (Trapasso et al., 2000) . However, it is conceivable that other pathways subserve the effects exerted by r-PTPZ. We have previously found that malignant r-PTPZ-transfected cells are more adherent to the substratum than their untransfected counterpart. This prompted us to investigate whether r-PTPZ interacts with c-Src, since c-Src activation is a feature of cell-substratum adhesion in various cells (Harder et al., 1998; Jones et al., 2002; Li et al., 2002) . In addition, there is evidence that the increased cell adhesion mediated by c-Src activation involves tyrosine phosphatase activity (Arregui et al., 1998; Harder et al., 1998; Jandt et al., 2003) . Here, we report that PTPZ interacts with c-Src in vitro and in vivo. In vitro interaction experiments demonstrate that c-Src cannot bind r-PTPZ exclusively by its SH2 domain since tyrosine residues from GST fusion proteins expressed in bacteria are not phosphorylated. r-PTPZ contains a Pro.X.X.Pro consensus sequence for SH3 domains. Thus, r-PTPZ could bind c-Src SH3 motif. However, to define the specific regions of interaction in both proteins, further investigation is required. In intact r-PTPZ-overexpressing cells, only the tyrosine located at position 529 on rat c-Src is dephosphorylated, whereas phosphorylation on Tyr 418 was unaffected. These data confirm the activating role of r-PTPZ on c-Src, since Tyr 418 dephosphorylation negatively regulates c-Src kinase activity (Bjorge et al., 2000; Petrone and Sap, 2000) . However, Tyr 418 is also dephosphorylated in vitro. This dephosphorylation might be not specific likely because of the high concentrations of recombinant r-PTPZ used for the in vitro experiments. Alternatively, it is possible that, in intact cells, the native folding could prevent the r-PTPZ catalytic pocket access to the c-Src activation loop where Tyr 418 is located; another possibility is that the dephosphorylation of Tyr 418 by r-PTPZ is immediately followed by its autophosphorylation or by its phosphorylation through other kinases (Smart et al., 1981; Chiang and Sefton, 2000) . Increased c-Src activity paralleled the dephosphorylation of the inhibitory phosphotyrosine. Adhesion to the substratum was significantly higher in PC MPSV/r-PTPZ-transfected cells than in untransfected cells or in cells transfected with the catalytically inactive r-PTPZ C/S mutant. Increased adhesion depended on the increase in c-Src tyrosine kinase activity, because adhesion decreased in rat thyroid cells treated with the c-Src inhibitor PP2. Interestingly, adhesion to the substratum was slightly higher in PC MPSV cells transfected with r-PTPZ C/S than in parental cells. This effect is probably due to the eight fibronectin-like domains located in the extracellular region of r-PTPZ, since similar structures occur in proteins involved in cell-adhesion processes. It is noteworthy that, unlike the human homolog DEP-1 (Jandt et al., 2003) , r-PTPZ C/S did not exert a dominant-negative effect on cell-substratum adhesion. The lack of endogenous tyrosine phosphatase expression in PC MPSV cells accounts for this apparent discrepancy.
Since FAK and paxillin, two c-Src substrates, undergo enhanced tyrosine phosphorylation upon cell adhesion to extracellular matrix (Burridge et al., 1992; Kornberg et al., 1992) , we measured their tyrosine phosphorylation levels in our cell lines. FAK and paxillin tyrosine phosphorylation levels were higher in the r-PTPZ-transfected cells than in r-PTPZ C/Stransfected and untransfected cells. The tyrosine phosphorylation levels of FAK and paxillin depended on cSrc activity, because FAK and paxillin phosphorylation were significantly decreased in r-PTPZ-transfected PP2-treated cells. We further confirmed the r-PTPZ-mediated activation of the c-Src/FAK pathway also in the FRTL KiMPSV rat thyroid cell line (data not shown). There- Western blot analysis showed that dephosphorylation of c-Src tyrosine 529, and FAK and paxillin tyrosine phosphorylation in PC MPSV cells are proportional to the levels of r-PTPZ expression. These results have important implications for tumor biology because of the loss of heterozygosity of PTPRJ, the human homolog of r-PTPZ, found in several colon, lung, breast and thyroid cancers (Ruivenkamp et al., 2002; Iuliano et al. 2004) . Finally, very recently, DEP1/PTPRJ expression levels were found to be drastically reduced or absent also in human pancreatic cancer cells . Thus, gene dosage could be important for PTPRJdependent pathways, as we found in the case of activation of the c-Src/FAK pathway by r-PTPZ. Furthermore, in a recent paper (Massa et al., 2004) , the correlation between the expression of r-PTPZ and the responsivity to the antiproliferative effects of the somatostatin has been demonstrated in glioma cells, indicating that the expression levels of r-PTPZ are also critical in other r-PTPZ-dependent pathways. In addition, it has been suggested that PTPRJ polymorphisms differ in their tumor suppressor activity (Ruivenkamp et al., 2002; Iuliano et al. 2004) , and it would be intriguing to find whether distinct PTPRJ forms exert different effects on the pathway described herein.
From the data reported here and previously (Trapasso et al., 2000), we conclude that r-PTPZ exerts its activity via at least two pathways: (1) it inhibits cell proliferation by increasing p27 protein levels and (2) it increases cell adhesion by activating a c-Src/FAK pathway.
Materials and methods
Expression and purification of GST fusion proteins
The intracellular regions of wild-type r-PTPZ and mutated r-PTPZ C/S (carrying a Cys1118/Ser mutation in the catalytic domain) were amplified by PCR and cloned into pGEX-2TK (Amersham Biosciences) using the BamHI and EcoRI restriction enzyme sites. Expression of GST fusion proteins was induced in exponentially growing Escherichia coli (strain BL21) by the addition of IPTG (1 mM) and incubation at 301C for 2 h. Bacterial cells were harvested by centrifugation and lysed in a buffer containing 1% Triton X-100, 10% glycerol, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, one protease inhibitor mixture tablet per 10 ml of buffer (Completet, Roche Diagnostics) and 0.4 mg/ml lysozyme. Lysates were centrifuged at 10 000 g for 15 min at 41C and the GST fusion proteins were purified from extracts by binding to glutathione-agarose beads (Sigma Chemical Co.) for 2 h at 41C with rocking. The recombinant proteins were eluted from the beads with 10 mM glutathione and 50 mM TrisHCl, pH 8.0, dialysed against 50 mM Tris-HCl, pH 7.5, 50 mM NaCl and 1 mM EDTA, pH 8.0, and quantified by SDS-PAGE and Coomassie blue staining.
Cell culture
PC MPSV cells (Fusco et al., 1985) and FRTL KiMSV (Fusco et al., 1987) were maintained in culture at 371C and 5% CO 2 in Ham's F-12 Nutrient Mixture (Invitrogen-Life Technologies Inc.) supplemented with 5% calf serum, 100 U/ml penicillin G and 100 mg/ml streptomycin sulfate (Invitrogen-Life Technologies Inc.). Cell lines stably transfected with an empty vector (PC MPSV/PMV-7), wild-type r-PTPZ (PC MPSV/r-PTPZ or FRTL KiMSV/r-PTPZ) or its catalytic mutant (PC MPSV/r-PTPZ C/S) were generated as described elsewhere (Trapasso et al., 2000) . They were cultured in the above-reported F-12 medium supplemented with 400 mg/ml geneticin (G418, Invitrogen-Life Technologies Inc.). Several clones have been picked and expanded for further investigation. When pertinent, the c-Src inhibitors PP2 or SU6656 (Calbiochem) were added to culture media before immunoprecipitation experiments.
Antibodies
Rabbit polyclonal antibodies against r-PTPZ were generated in response to a recombinant protein fused to glutathione Stransferase containing the intracellular region of r-PTPZ (Trapasso et al., 2000) . Rabbit polyclonal antibodies against pan-Src, Src pY529 and Src pY418 were purchased from BioSource International. Anti-GST (B-14), anti-FAK (C-903) and anti-c-Src (SRC2) antibodies were purchased from Santa Cruz Biotechnology. Horseradish peroxidase (HRP)-conjugated anti-mouse and anti-rabbit immunoglobulins were also from Santa Cruz Biotechnology.
Phosphotyrosine (pTyr) mAb 4G10 and anti-c-Src GD11 were from Upstate Biotechnology. Mouse monoclonal antibodies to paxillin were purchased from Transduction Laboratories.
In vitro binding assay
For the in vitro interaction assay with GST fusion proteins, 500 mg of total cell lysate from malignant rat thyroid cells (PC MPSV) was diluted to 1 mg/ml with a buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% NP-40, 1 mM dithiothreitol and 5 mg/ml each aprotinin and leupeptin. Lysates were incubated with 3 mg of GST-PTPZ or purified GST proteins. After incubation at 41C and rocking for 1 h and 30 min, each mixture was immunoprecipitated with 4 mg anti-c-Src (clone GD11). The immunoprecipitates were resolved on 12% SDS-PAGE gel and subjected to immunoblot analysis with anti-GST antibodies.
Cell lysis, immunoprecipitation and Western blot analysis
Cells were scraped in ice-cold phosphatase-buffered saline (PBS) and lysed in NP-40 lysis buffer containing 50 mM TrisHCl, pH 7.5, 150 mM NaCl, 1% NP-40, one protease inhibitor mixture tablet per 10 ml of buffer (Completet, Roche Diagnostics), 1 mM Na 3 VO 4 and 50 mM NaF. Lysates were passed several times through a 21-gauge needle and incubated for 30 min on ice. Cellular debris was pelleted by centrifugation at 10 000 g for 15 min at 41C. Protein concentrations were determined using the Bradford protein assay dye (Bio-Rad).
For immunoprecipitation, 100 mg-1 mg cell lysate was incubated with 2-4 mg of primary antibodies for 1 h or overnight at 41C with rotation. Immunocomplexes were collected using 20 ml of protein G-agarose, Fast Flow (Upstate Biotechnology) or 100 ml of protein A-agarose, Fast Flow (Upstate Biotechnology) by rotating at 41C for 3 h. Immunoprecipitates were washed three times with 800 ml of NP-40 lysis buffer and resuspended in Laemmli sample buffer for Western blot analysis.
For the in vivo c-Src/r-PTPZ interaction, protein extraction and immunoprecipitation were carried out with a binding/lysis r-PTPg increases cell adhesion by activating c-Src I Le Pera et al buffer containing 50 mM Tris-HCl, pH 7.2, 50 mM NaCl, 10% glycerol, 2 mM EDTA, pH 8.0, 1% NP-40, 50 mM NaF, 1 mM Na 3 VO 4 and 10 mg/ml each aprotinin and leupeptin (Zheng et al., 2000) . Total cell lysates or immunoprecipitates were separated by SDS-PAGE and transferred to PVDF membranes. The membranes were blocked in 5% nonfat dry milk (Bio-Rad) and then probed for about 2 h with primary antibodies. After incubation with specific (HRP)-conjugated secondary antibodies, protein bands were revealed by the ECL detection system (Santa Cruz Biotechnology). To determine the level of phosphotyrosine, 1% bovine serum albumin (Sigma Chemical Co.) was used as blocking agent in the place of milk.
In vitro dephosphorylation assay
Endogenous Src was immunoprecipitated from 500 mg of PC MPSV proteins. Immunoprecipitates were washed three times in NP-40 buffer and once in a phosphatase buffer (50 mM TrisHCl, pH 6.8, 150 mM NaCl, 1 mM EDTA, pH 8.0, 10 mM dithiothreitol) without phosphatase inhibitors. Immunocomplexes were then resuspended in phosphatase buffer and divided into four equal aliquots, which were incubated alone or with 3 or 0.5 mg of GST-PTPZ or with 3 mg of GST-PTPZ C/ S. After 10 min at 371C, the dephosphorylation reactions were terminated and aliquots were analysed by SDS-PAGE and Western blotting.
Src kinase assay
c-Src was immunoprecipitated from 400 mg of total proteins extracted from parental and transfected PC MPSV cells. Each immunoprecipitate was washed three times with NP-40 buffer and once with the same buffer containing a high salt concentration (0.5 M NaCl). Immunoprecipitates were then washed and resuspended in kinase buffer (100 mM Tris-HCl, pH 7.2, 125 mM MgCl 2 , 25 mM MnCl 2 , 2 mM EGTA, 250 mM Na 3 VO 4 , 2 mM DTT). c-Src activity was measured using a Src assay kit (Upstate Biotechnology). Briefly, Src immunoprecipitates were incubated in kinase buffer containing a synthetic Src-specific substrate peptide (KVEKIGEGTYGVVYK) and 10 mCi of [g-32 P]ATP for 10 min at 301C with agitation. The amount of phosphorylated substrate was quantified by measuring its radioactivity with a scintillation counter.
Cell-substratum adhesion assay
The assay was performed as described elsewhere (Harder et al., 1998) with some modifications. Either untransfected or stably transfected PC MPSV cells with the empty vector, PC MPSV/ r-PTPZ and PC MPSV/r-PTPZ C/S cells were plated in 24-well flat bottom plates in quadruplicate at a density of 1 Â 10 5 cells/ well. Cells were incubated at 371C for 1 day and then gently washed 2-3 times with 500 ml of Ca 2 þ -and Mg 2 þ -free PBS/ well/wash for 4-6 min. After the last wash, 500 ml of culture medium and 50 ml of cell proliferation reagent WST-1 (Roche Diagnostics) were added to each well; 2 h and 30 min later, the absorbance at 450 nm was measured with a microtiter plate (ELISA) reader. The absorbance of each well was compared with untreated wells to determine the percentage of cells removed by each washing protocol. To evaluate the effects of c-Src inhibition on cell-substratum adhesion, PC MPSV untransfected and transfected cells were incubated for 1 h at 371C in either the absence or presence of 10 mM of the c-Src inhibitor PP2 (Calbiochem). The adhesion assay was then performed, as described above, to analyse adherence changes in every treated cells.
